If you’re hoping to hit the high seas in Blox Fruits, here are some tips for leveling that’ll turn you from sadsack to ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Secure and simplify your digital life with Senior Planet from ...

Single-pill medications that combine two or more blood pressure medications could simplify treatment to help more adults with high blood pressure achieve target blood pressure levels faster and ...

Taking one pill that combines two or more blood pressure medications may help adults with high blood pressure (also known as hypertension) lower their blood pressure level faster and more effectively ...

NSW Health has issued alerts for 14 MDMA pills this year, found to contain dangerously high doses of the drug, including tablets stamped with Boba Fett, Red Bull, Phillip Plein and grenade-style ...

A 27-year-old man who was allegedly driving drunk when he veered off of an Anaheim street and crashed into a group of high school athletes on a training run Wednesday afternoon was identified by ...

An Ohio physician is facing a litany of felony charges following allegations that he attempted to force abortion-inducing medication on his pregnant girlfriend while she was asleep. A Lucas County ...

The Volkswagen Group of America is recalling a small population of ID.4 vehicles equipped with battery cells that may have been manufactured with misaligned electrodes. SK Battery America is the ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR) on Monday released clinical results from the BroADen Phase 1b atopic dermatitis (AD) clinical trial of KT-621, its oral STAT6 degrader medicine. STAT6 ...

The logo of the US Food and Drug Administration (FDA) is seen on a sign outside the agency’s White Oak campus in Silver Spring, Maryland, on July 17, 2025. (Photo by Issam AHMED / AFP) (Photo by ISSAM ...

NEW YORK (PIX11) – Thousands of bottles of a popular combination drug used to treat high blood pressure have been recalled across the United States, according to the Federal Drug Administration.

A phase III trial of investigational valiltramiprosate (ALZ-801) did not meet its primary endpoint in people with early symptomatic Alzheimer's disease, but the drug did show benefits in a ...